We are live on ! Find out more
ECP

Epacria Capital Partners Portfolio holdings

AUM $129M
1-Year Est. Return 22.34%
This Fund
S&P 500
This Quarter Est. Return
+5.78%
1 Year Est. Return
+22.34%
3 Year Est. Return
+85.79%
5 Year Est. Return
10 Year Est. Return
AUM
$120M
AUM Growth
-$3.14M
Cap. Flow
-$8.41M
Cap. Flow %
-7.02%
Top 10 Hldgs %
76.69%
Holding
41
New
1
Increased
9
Reduced
2
Closed
7

Sector Composition

Rank Sector Weight
1 Consumer Staples 29.02%
2 Financials 22.65%
3 Energy 19.24%
4 Technology 2.43%
5 Real Estate 1.9%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
NEN icon
26
New England Realty Associates
NEN
$196M
$631K 0.53%
8,636
DEO icon
27
Diageo
DEO
$48.8B
$402K 0.34%
3,989
VAL.WS icon
28
Valaris Ltd Warrants
VAL.WS
$642M
$323K 0.27%
83,658
MAA icon
29
Mid-America Apartment Communities
MAA
$15.5B
$297K 0.25%
2,008
EXPD icon
30
Expeditors International
EXPD
$22.3B
$251K 0.21%
2,200
CRESW
31
DELISTED
Cresud SACIF y A. Warrant
CRESW
$249K 0.21%
295,967
MRVI icon
32
Maravai LifeSciences
MRVI
$947M
$226K 0.19%
93,694
+38,264
+69% +$80.4K
CLPT icon
33
ClearPoint Neuro
CLPT
$386M
$140K 0.12%
+11,729
New +$148K
MXCT icon
34
MaxCyte
MXCT
$115M
$135K 0.11%
62,133
+39,796
+178% +$96.4K
GOLD
35
Gold.com Inc
GOLD
$1.24B
-16,600
Closed -$421K
BUR icon
36
Burford Capital
BUR
$931M
-23,291
Closed -$308K
DVA icon
37
DaVita
DVA
$14.6B
-4,107
Closed -$628K
JEF icon
38
Jefferies Financial Group
JEF
$12.8B
-27,381
Closed -$1.47M
LILAK icon
39
Liberty Latin America Class C
LILAK
$1.67B
-151,529
Closed -$847K
PKE icon
40
Park Aerospace
PKE
$774M
-70,282
Closed -$945K
RPRX icon
41
Royalty Pharma
RPRX
$25.3B
-18,440
Closed -$574K

Similar funds

Epacria Capital Partners's Q2 2025 Portfolio in Review

As of Q2 2025, Epacria Capital Partners held 41 positions worth $120M, down 2.6% from $123M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Epacria Capital Partners withdrew a net $8.41M in Q2 2025, closing 7 positions and reducing 2 holdings. Its most notable exit was Jefferies Financial Group, an estimated $1.47M position sold in full.

By sector, the portfolio is most concentrated in Consumer Staples at 29% of assets, up from 25% a quarter earlier, followed by Financials and Energy.

Against the trend, Epacria Capital Partners opened a new position in ClearPoint Neuro worth $140K.

  • Epacria Capital Partners's largest Q2 2025 buy was ClearPoint Neuro: 11,729 shares worth $140K.
  • Epacria Capital Partners added most to Alpha Architect 1-3 Month Box ETF in Q2 2025, an estimated $533K increase.
  • Epacria Capital Partners's biggest Q2 2025 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.47M.
  • Epacria Capital Partners fully exited Jefferies Financial Group in Q2 2025, selling an estimated $1.47M.
  • Epacria Capital Partners's ten largest holdings make up 77% of its $120M portfolio in Q2 2025.
  • Epacria Capital Partners opened 1 new position and closed 7 in Q2 2025.
  • Epacria Capital Partners's portfolio value fell 2.6% quarter-over-quarter to $120M.

Based on Epacria Capital Partners's 13F filing for Q2 2025, filed 13 Aug 2025.